Basel, 2000/03/21

Genedata AG, a privately-held Swiss bioinformatics company, today announced its move into the Japanese life science market. The company has assigned Teijin Systems Technology Ltd. (TST), one of Japan's leading distributors in the field of scientific software, to be its representative for the Japanese life science market.

Genedata's CEO, Othmar Pfannes, Ph.D., states: "We are happy to announce this partnership with TST and strongly believe that we have identified a competent and experienced partner for our entry into the growing Japanese genomics market. TST enables us to provide the required high quality bioinformatics support for our Japanese customers. Japanese scientists are performing cutting edge research in areas such as microarray-based gene expression, proteomics and complete genome analysis. Genedata's integrated software platform for functional genomics will enable an accelerated understanding of complex biological processes and provide a competitive advantage to the life science industry." To tackle the high data complexity in functional genomics Genedata provides state-of the-art software along with services for data analysis consulting as well as software and database customization.

Mr. Shigeru Katsumata, TST's General Manager, says: "TST has been engaged in the Japanese bioinformatics market for about 15 years, and we are proud to now offer Genedata's worldwide leading products to our customers. We believe that the cooperation of TST and Genedata will provide competitive solutions for the Japanese pharmaceutical, agrochemical and biotechnology industries."

TST will be responsible for the promotion in Japan of Genedata's software systems in the areas of genome analysis and genome data management (Phylosopher), sequence analysis (WorkBench), gene expression data analysis (Expressionist), and proteomics data analysis (Impressionist).